Upgrade to SI Premium - Free Trial

Insmed (INSM) Misses Q4 EPS by 2c

February 25, 2016 8:06 AM

Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.51), $0.02 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Insmed (INSM) click here.

Categories

Earnings

Next Articles